ATP7A and colorectal carcinoma: In addition, we also found that the expression of Cav‐1, a protein reported to regulate the stability of ATP7A, is not obviously changed upon treatment of elesclomol, suggesting that Cav‐1 may not be involved in elesclomol‐induced ATP7A degradation in CRC cells.